Epigallocatechin-3-gallate Inhibits LPS-Induced NF-κB and MAPK Signaling Pathways in Bone Marrow-Derived Macrophages

Regulation of lipopolysaccharide-induced inflammatory response by heat shock protein 27 in THP-1 cells

(2010) Junhong Liu et al.   CELLULAR IMMUNOLOGY

Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice

(2010) Susana Sánchez-Fidalgo et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Reactive Oxygen Species Level Defines Two Functionally Distinctive Stages of Inflammatory Dendritic Cell Development from Mouse Bone Marrow

(2010) K.-C. Sheng et al.   JOURNAL OF IMMUNOLOGY

Biologic Therapies Against Inflammatory Bowel Disease: A Dysregulated Immune System and the Cross Talk with Gastrointestinal Mucosa Hold the Key

(2010) Poonam Dharmani et al.   Current Molecular Pharmacology

Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro

(2009) Esther Melgarejo et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cellular signaling perturbation by natural products

(2009) Fazlul H. Sarkar et al.   CELLULAR SIGNALLING

Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid

(2008) Zhi Hua Ran et al.   BIOMEDICINE & PHARMACOTHERAPY

Multitargeted therapy of cancer by green tea polyphenols

(2008) Naghma Khan et al.   CANCER LETTERS

Microbial Influences in Inflammatory Bowel Diseases

(2008) R. Balfour Sartor   GASTROENTEROLOGY

The anti-inflammatory and anti-cancer properties of epigallocatechin-3-gallate are mediated by folate cycle disruption, adenosine release and NF-κB suppression

(2008) E. Navarro-Perán et al.   INFLAMMATION RESEARCH

Role of cytokines in inflammatory bowel disease

(2008) Fausto Sanchez-Muñoz et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis

(2007) Patricia A. Abboud et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

NF-κB and the intestine: Friend or foe?

(2007) Thomas Karrasch et al.   INFLAMMATORY BOWEL DISEASES